Ā | n (%) |
---|---|
Number of patients | 66 |
Median age at diagnosis (range) | 51.8 (23.3ā90.1) |
Histology | Squamous: 54 (82Ā %) |
Adenocarcinoma: 7 (11Ā %) | |
Adenosquamous: 5 (8Ā %) | |
Grade (differentiation) | Well: 4 (6Ā %) |
Moderate: 43 (65Ā %) | |
Poor: 19 (29Ā %) | |
FIGO Stage (2009) | IB1-2: 2 (3Ā %) |
IIA1-IIB: 42 (64Ā %) | |
IIIA-B: 16 (24Ā %) | |
IVA-B: 6 (9Ā %) | |
Median External beam radiotherapy dose (range) | 44.92Ā Gy (39.6ā59.4) |
Median HDR Brachytherapy dose (range) | 27.05Ā Gy (21ā28) |
Median Total external beam and brachytherapy dose as an EQD2 (range) | 82.2Ā Gy (74ā83.9) |
Concurrent chemotherapy | 58 (88Ā %) |